TOKYO Japanese researchers performed the world's first transplant of retina cells made from donor-derived induced pluripotent stem (iPS) cells into a patient's eye in late March. Compared with using the patient's own cells to create the iPS cells, the cost and time needed to prepare for surgery can be reduced to less than one tenth.
The clinical study on March 28 was conducted by a team involving the government-affiliated research institute Riken, Kobe City Medical Center General Hospital, Kyoto University and other entities.
